Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lesinurad and Febuxostat Combination Extension Study in Gout

ClinicalTrials.gov ID: NCT01808144

Public ClinicalTrials.gov record NCT01808144. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 11:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term Extension Study of Lesinurad in Combination With Febuxostat for Subjects With Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with febuxostat over a long-term timeframe.

Study identification

NCT ID
NCT01808144
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ardea Biosciences, Inc.
Industry
Enrollment
196 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2013
Primary completion
Aug 8, 2016
Completion
Oct 5, 2016
Last update posted
Jan 29, 2018

2013 – 2016

United States locations

U.S. sites
55
U.S. states
26
U.S. cities
53
Facility City State ZIP Site status
Not listed Birmingham Alabama 35211
Not listed Tempe Arizona 85282
Not listed Glendale California 91204
Not listed Huntington Beach California 92646
Not listed Irvine California 92618
Not listed San Diego California 92108
Not listed Denver Colorado 80220
Not listed Englewood Colorado 80113
Not listed Boynton Beach Florida 33472
Not listed Naples Florida 34102
Not listed Pembroke Pines Florida 33027
Not listed Tampa Florida 33606
Not listed Tampa Florida 33614
Not listed Winter Haven Florida 33880
Not listed Johns Creek Georgia 30097
Not listed Honolulu Hawaii 96814
Not listed Meridian Idaho 83646
Not listed Gurnee Illinois 60031
Not listed Springfield Illinois 62704
Not listed Elizabethtown Kentucky 42701
Not listed Frederick Maryland 21702
Not listed Ann Arbor Michigan 48109
Not listed Southfield Michigan 48034
Not listed Jackson Mississippi 39202
Not listed Olive Branch Mississippi 38654
Not listed Jefferson City Missouri 65109
Not listed St Louis Missouri 63117
Not listed New York New York 10036
Not listed Wilmington North Carolina 28401
Not listed Fargo North Dakota 58103
Not listed Columbus Ohio 43203
Not listed Middleburg Heights Ohio 44130
Not listed Wadsworth Ohio 44281
Not listed Oklahoma City Oklahoma 73103
Not listed Belle Vernon Pennsylvania 15012
Not listed Lansdale Pennsylvania 19446
Not listed Pittsburgh Pennsylvania 15206
Not listed Sellersville Pennsylvania 18960
Not listed Columbia South Carolina 29204
Not listed Mt. Pleasant South Carolina 29464
Not listed Spartanburg South Carolina 29303
Not listed Memphis Tennessee 38119
Not listed Austin Texas 78705
Not listed Austin Texas 78758
Not listed Dallas Texas 75218
Not listed Houston Texas 77074
Not listed San Antonio Texas 78229
Not listed Sugar Land Texas 77479
Not listed Victoria Texas 77901
Not listed Waco Texas 76710
Not listed Chesapeake Virginia 23320
Not listed Danville Virginia 24541
Not listed Richmond Virginia 23235
Not listed Seattle Washington 98104
Not listed Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01808144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2018 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01808144 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →